Research Solutions, Inc. (NASDAQ:RSSS – Get Free Report) saw a large decline in short interest during the month of February. As of February 28th, there was short interest totalling 42,000 shares, a decline of 62.9% from the February 13th total of 113,300 shares. Based on an average daily volume of 181,000 shares, the short-interest ratio is presently 0.2 days. Approximately 0.1% of the shares of the company are short sold.
Research Solutions Price Performance
NASDAQ:RSSS traded up $0.04 during trading hours on Friday, hitting $2.97. 19,307 shares of the company were exchanged, compared to its average volume of 133,812. The stock has a market capitalization of $96.96 million, a price-to-earnings ratio of -19.80, a PEG ratio of 4.33 and a beta of 0.55. Research Solutions has a 52-week low of $2.38 and a 52-week high of $4.24. The company’s 50 day moving average price is $3.55 and its 200-day moving average price is $3.25.
Research Solutions (NASDAQ:RSSS – Get Free Report) last released its earnings results on Thursday, February 13th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.09). The company had revenue of $11.91 million for the quarter, compared to analysts’ expectations of $11.86 million. Research Solutions had a negative return on equity of 6.59% and a negative net margin of 8.41%. On average, equities analysts predict that Research Solutions will post 0.05 earnings per share for the current year.
Institutional Trading of Research Solutions
Research Solutions Company Profile
Research Solutions, Inc, through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer’s internal datasets.
Further Reading
- Five stocks we like better than Research Solutions
- How to invest in marijuana stocks in 7 steps
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Research Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Solutions and related companies with MarketBeat.com's FREE daily email newsletter.